Advances and perspectives on cellular therapy in acquired bone marrow failure diseases

doi:10.5315/wjh.v5.i1.31

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8562)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

480

WORD

320

HTML

5126

Figures (1-1)

247

Tables (1-1)

153

Sum=6326

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

881

Download

1355

Sum=2236

Feb 6, 2016 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hematol. Feb 6, 2016; 5(1): 31-36
Published online Feb 6, 2016. doi: 10.5315/wjh.v5.i1.31

Open in New Tab Full Size Figure Download Figure

Figure 1 Typical clinical presentation of aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria. AA: Aplastic anemia; MDS: Myelodysplastic syndrome; PNH: Paroxysmal nocturnal hemoglobinuria.

Citation: Sun XS, Liu X, Xu KL, Chen A, Rybka WB, Pu JJ. Advances and perspectives on cellular therapy in acquired bone marrow failure diseases. World J Hematol 2016; 5(1): 31-36
URL: https://www.wjgnet.com/2218-6204/full/v5/i1/31.htm
DOI: https://dx.doi.org/10.5315/wjh.v5.i1.31